KMDA
Price
$8.31
Change
+$0.11 (+1.34%)
Updated
Oct 2 closing price
Capitalization
501.22M
44 days until earnings call
Intraday BUY SELL Signals
RGC
Price
$6.82
Change
+$0.49 (+7.74%)
Updated
Oct 2 closing price
Capitalization
3.07B
Intraday BUY SELL Signals
Interact to see
Advertisement

KMDA vs RGC

KMDA vs RGC Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KMDA vs. RGC commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and RGC is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
KMDA vs RGC: Fundamental Ratings
KMDA
RGC
OUTLOOK RATING
1..100
7742
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
40100
SMR RATING
1..100
76100
PRICE GROWTH RATING
1..100
4664
P/E GROWTH RATING
1..100
33100
SEASONALITY SCORE
1..100
3150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KMDA's Valuation (6) in the Biotechnology industry is significantly better than the same rating for RGC (94) in the Movies Or Entertainment industry. This means that KMDA’s stock grew significantly faster than RGC’s over the last 12 months.

KMDA's Profit vs Risk Rating (40) in the Biotechnology industry is somewhat better than the same rating for RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew somewhat faster than RGC’s over the last 12 months.

KMDA's SMR Rating (76) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's Price Growth Rating (46) in the Biotechnology industry is in the same range as RGC (64) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's P/E Growth Rating (33) in the Biotechnology industry is significantly better than the same rating for RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew significantly faster than RGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDARGC
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
63%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
69%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
88%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (KMDA: $8.31 vs. RGC: $6.82)
Brand notoriety: KMDA and RGC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KMDA: 35% vs. RGC: 225%
Market capitalization -- KMDA: $501.22M vs. RGC: $3.07B
KMDA [@Pharmaceuticals: Generic] is valued at $501.22M. RGC’s [@Pharmaceuticals: Generic] market capitalization is $3.07B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 2 FA rating(s) are green while RGC’s FA Score has 0 green FA rating(s).

  • KMDA’s FA Score: 2 green, 3 red.
  • RGC’s FA Score: 0 green, 5 red.
According to our system of comparison, KMDA is a better buy in the long-term than RGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 4 TA indicator(s) are bullish while RGC’s TA Score has 5 bullish TA indicator(s).

  • KMDA’s TA Score: 4 bullish, 5 bearish.
  • RGC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RGC is a better buy in the short-term than KMDA.

Price Growth

KMDA (@Pharmaceuticals: Generic) experienced а -4.70% price change this week, while RGC (@Pharmaceuticals: Generic) price change was +10.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.61%. For the same industry, the average monthly price growth was -8.00%, and the average quarterly price growth was +30.03%.

Reported Earning Dates

KMDA is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
KMDA
Daily Signal:
Gain/Loss:
RGC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STKE1.710.04
+2.40%
Sol Strategies Inc
IPI32.760.16
+0.49%
Intrepid Potash
TECH72.40N/A
N/A
Bio-Techne Corp
ONBPO24.81-0.05
-0.20%
Old National Bancorp
CHA10.98-0.16
-1.44%
Chagee Holdings Ltd

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and TEVA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and TEVA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+1.34%
TEVA - KMDA
25%
Poorly correlated
+0.56%
CRDL - KMDA
25%
Poorly correlated
-9.62%
INM - KMDA
25%
Poorly correlated
-1.48%
SIGA - KMDA
25%
Poorly correlated
+0.90%
OGI - KMDA
25%
Poorly correlated
-2.97%
More

RGC and

Correlation & Price change

A.I.dvisor tells us that RGC and HIMS have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and HIMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
+7.74%
HIMS - RGC
22%
Poorly correlated
-1.02%
KMDA - RGC
21%
Poorly correlated
+1.34%
QNTM - RGC
21%
Poorly correlated
+0.44%
ACB - RGC
21%
Poorly correlated
+0.51%
SBFM - RGC
20%
Poorly correlated
-3.05%
More